Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCL
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Lenalidomide (Primary) ; Romidepsin (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 12 Jul 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 01 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.